Adaptimmune Therapeutics vs Janux Therapeutics
Adaptimmune Therapeutics vs Janux Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptimmune Therapeutics is on 44/100 and Janux Therapeutics on 57/100.
Where each one leads
Adaptimmune Therapeutics
- domain rating: 52/100 against 39/100
- headcount: 191 against 110
- LinkedIn following: 54,208 against 12,449
Janux Therapeutics
- our overall score: 57/100 against 44/100
- funding raised: $181M against $107M
At a glance
| Measure | Adaptimmune Therapeutics | Janux Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company developing T-cell therapies for solid tumor cancers. | A clinical-stage biopharmaceutical company developing novel immunotherapies. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Cancer Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2017 |
| Headquarters | Abingdon, United Kingdom | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptimmune Therapeutics | Janux Therapeutics |
|---|---|---|
| Employees | 191 | 110 |
| Total funding | $107M | $181M |
| Latest round | Series A | Series B |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 54,208 | 12,449 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptimmune Therapeutics | Janux Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 57/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 30/100 | 35/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptimmune Therapeutics | Janux Therapeutics |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Linkedin Insight | Google Tag Manager |
Adaptimmune Therapeutics vs Janux Therapeutics: common questions
Which is better, Adaptimmune Therapeutics or Janux Therapeutics?
On our 0-100 score Janux Therapeutics rates higher (57/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Adaptimmune Therapeutics and Janux Therapeutics compare on the numbers?
Adaptimmune Therapeutics leads on domain rating (52/100 against 39/100), headcount (191 against 110), LinkedIn following (54,208 against 12,449). Janux Therapeutics leads on our overall score (57/100 against 44/100), funding raised ($181M against $107M).
Read the full Adaptimmune Therapeutics review and pricing or the Janux Therapeutics review and pricing. You can also browse other Adaptimmune Therapeutics alternatives we track.